ID GFRA2_HUMAN Reviewed; 464 AA. AC O00451; E9PD47; O15316; O15328; Q58J92; Q6GTR9; Q7Z5C2; DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot. DT 31-OCT-2006, sequence version 2. DT 24-JAN-2024, entry version 183. DE RecName: Full=GDNF family receptor alpha-2; DE Short=GDNF receptor alpha-2; DE Short=GDNFR-alpha-2; DE Short=GFR-alpha-2; DE AltName: Full=GDNF receptor beta; DE Short=GDNFR-beta; DE AltName: Full=Neurturin receptor alpha; DE Short=NRTNR-alpha; DE Short=NTNR-alpha; DE AltName: Full=RET ligand 2; DE AltName: Full=TGF-beta-related neurotrophic factor receptor 2; DE Flags: Precursor; GN Name=GFRA2; Synonyms=GDNFRB, RETL2, TRNR2; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND VARIANT GLN-462. RX PubMed=9182803; DOI=10.1016/s0896-6273(00)80318-9; RA Baloh R.H., Tansey M.G., Golden J.P., Creedon D.J., Heuckeroth R.O., RA Keck C.L., Zimonjic D.B., Popescu N.C., Johnson E.M. Jr., Milbrandt J.; RT "TrnR2, a novel receptor that mediates neurturin and GDNF signaling through RT Ret."; RL Neuron 18:793-802(1997). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLN-462. RC TISSUE=Fetal brain; RX PubMed=9259272; DOI=10.1093/hmg/6.8.1267; RA Suvanto P., Wartiovaara K., Lindahl M., Arumae U., Moshnyakov M., RA Horelli-Kuitunen N., Airaksinen M.S., Palotie A., Sariola H., Saarma M.; RT "Cloning, mRNA distribution and chromosomal localisation of the gene for RT glial cell line-derived neurotrophic factor receptor beta, a homologue to RT GDNFR-alpha."; RL Hum. Mol. Genet. 6:1267-1273(1997). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RC TISSUE=Liver; RX PubMed=9177201; DOI=10.1073/pnas.94.12.6238; RA Sanicola M., Hession C.A., Worley D.S., Carmillo P., Ehrenfels C., RA Walus L., Robinson S., Jaworski G., Wei H., Tizard R., Whitty A., RA Pepinsky R.B., Cate R.L.; RT "Glial cell line-derived neurotrophic factor-dependent RET activation can RT be mediated by two different cell-surface accessory proteins."; RL Proc. Natl. Acad. Sci. U.S.A. 94:6238-6243(1997). RN [4] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), AND VARIANT GLN-462. RA Yoong L.F., Too H.P.; RL Submitted (FEB-2005) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16421571; DOI=10.1038/nature04406; RA Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M., RA Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L., RA Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S., RA Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A., RA Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III, RA Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., RA Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P., RA Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H., RA Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B., RA O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K., RA Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L., RA Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G., RA Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W., RA Platzer M., Shimizu N., Lander E.S.; RT "DNA sequence and analysis of human chromosome 8."; RL Nature 439:331-335(2006). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [7] RP INTERACTION WITH SORL1. RX PubMed=23333276; DOI=10.1016/j.celrep.2012.12.011; RA Glerup S., Lume M., Olsen D., Nyengaard J.R., Vaegter C.B., Gustafsen C., RA Christensen E.I., Kjolby M., Hay-Schmidt A., Bender D., Madsen P., RA Saarma M., Nykjaer A., Petersen C.M.; RT "SorLA controls neurotrophic activity by sorting of GDNF and its receptors RT GFRalpha1 and RET."; RL Cell Rep. 3:186-199(2013). CC -!- FUNCTION: Receptor for neurturin. Mediates the NRTN-induced CC autophosphorylation and activation of the RET receptor. Also able to CC mediate GDNF signaling through the RET tyrosine kinase receptor. CC -!- FUNCTION: [Isoform 2]: Participates in NRTN-induced 'Ser-727' CC phosphorylation of STAT3. {ECO:0000250|UniProtKB:O08842}. CC -!- SUBUNIT: Interacts with SORL1. {ECO:0000269|PubMed:23333276}. CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor, GPI- CC anchor {ECO:0000250}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=3; CC Name=1; Synonyms=Long; CC IsoId=O00451-1; Sequence=Displayed; CC Name=2; Synonyms=Short; CC IsoId=O00451-2; Sequence=VSP_001661; CC Name=3; CC IsoId=O00451-3; Sequence=VSP_046112; CC -!- TISSUE SPECIFICITY: Isoform 1 is found in both brain and placenta. CC -!- SIMILARITY: Belongs to the GDNFR family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF002700; AAC52036.1; -; mRNA. DR EMBL; U93703; AAB61922.1; -; mRNA. DR EMBL; U97145; AAC51647.1; -; mRNA. DR EMBL; AY326396; AAP88378.1; -; mRNA. DR EMBL; AY941828; AAX46325.1; -; mRNA. DR EMBL; AC105186; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC129925; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AP008236; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC041688; AAH41688.1; -; mRNA. DR CCDS; CCDS47816.1; -. [O00451-1] DR CCDS; CCDS55207.1; -. [O00451-2] DR CCDS; CCDS55208.1; -. [O00451-3] DR RefSeq; NP_001158510.1; NM_001165038.1. [O00451-3] DR RefSeq; NP_001158511.1; NM_001165039.1. [O00451-2] DR RefSeq; NP_001486.4; NM_001495.4. [O00451-1] DR RefSeq; XP_006716390.1; XM_006716327.3. [O00451-1] DR RefSeq; XP_011542786.1; XM_011544484.2. [O00451-1] DR PDB; 5MR4; X-ray; 2.40 A; C/D=1-458. DR PDB; 5MR5; X-ray; 2.00 A; C/D=147-362. DR PDB; 6GL7; EM; 6.30 A; C/D=22-441. DR PDB; 6Q2O; EM; 3.65 A; C/D=24-362. DR PDB; 6Q2R; EM; 4.30 A; C/D/W/X=24-362. DR PDBsum; 5MR4; -. DR PDBsum; 5MR5; -. DR PDBsum; 6GL7; -. DR PDBsum; 6Q2O; -. DR PDBsum; 6Q2R; -. DR AlphaFoldDB; O00451; -. DR EMDB; EMD-0026; -. DR EMDB; EMD-20576; -. DR EMDB; EMD-20578; -. DR SMR; O00451; -. DR BioGRID; 108943; 4. DR STRING; 9606.ENSP00000428518; -. DR GlyCosmos; O00451; 5 sites, 3 glycans. DR GlyGen; O00451; 6 sites, 4 O-linked glycans (3 sites). DR iPTMnet; O00451; -. DR PhosphoSitePlus; O00451; -. DR BioMuta; GFRA2; -. DR MassIVE; O00451; -. DR PaxDb; 9606-ENSP00000428518; -. DR PeptideAtlas; O00451; -. DR ProteomicsDB; 19584; -. DR ProteomicsDB; 47897; -. [O00451-1] DR ProteomicsDB; 47898; -. [O00451-2] DR Antibodypedia; 5212; 443 antibodies from 35 providers. DR DNASU; 2675; -. DR Ensembl; ENST00000517328.5; ENSP00000429445.1; ENSG00000168546.11. [O00451-1] DR Ensembl; ENST00000517892.5; ENSP00000429979.1; ENSG00000168546.11. [O00451-3] DR Ensembl; ENST00000518077.5; ENSP00000429206.1; ENSG00000168546.11. [O00451-2] DR Ensembl; ENST00000524240.6; ENSP00000428518.1; ENSG00000168546.11. [O00451-1] DR GeneID; 2675; -. DR KEGG; hsa:2675; -. DR MANE-Select; ENST00000524240.6; ENSP00000428518.1; NM_001495.5; NP_001486.4. DR UCSC; uc003wzu.2; human. [O00451-1] DR AGR; HGNC:4244; -. DR CTD; 2675; -. DR DisGeNET; 2675; -. DR GeneCards; GFRA2; -. DR HGNC; HGNC:4244; GFRA2. DR HPA; ENSG00000168546; Tissue enhanced (testis, thyroid gland). DR MIM; 601956; gene. DR neXtProt; NX_O00451; -. DR OpenTargets; ENSG00000168546; -. DR PharmGKB; PA28654; -. DR VEuPathDB; HostDB:ENSG00000168546; -. DR eggNOG; ENOG502QS3P; Eukaryota. DR GeneTree; ENSGT00940000156168; -. DR HOGENOM; CLU_040179_1_1_1; -. DR InParanoid; O00451; -. DR OMA; DTGKPCN; -. DR OrthoDB; 3899332at2759; -. DR PhylomeDB; O00451; -. DR TreeFam; TF331647; -. DR PathwayCommons; O00451; -. DR Reactome; R-HSA-419037; NCAM1 interactions. DR Reactome; R-HSA-5673001; RAF/MAP kinase cascade. DR Reactome; R-HSA-8853659; RET signaling. DR SignaLink; O00451; -. DR SIGNOR; O00451; -. DR BioGRID-ORCS; 2675; 14 hits in 1146 CRISPR screens. DR ChiTaRS; GFRA2; human. DR GeneWiki; GFRA2_(gene); -. DR GenomeRNAi; 2675; -. DR Pharos; O00451; Tbio. DR PRO; PR:O00451; -. DR Proteomes; UP000005640; Chromosome 8. DR RNAct; O00451; Protein. DR Bgee; ENSG00000168546; Expressed in secondary oocyte and 128 other cell types or tissues. DR ExpressionAtlas; O00451; baseline and differential. DR GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central. DR GO; GO:0019898; C:extrinsic component of membrane; TAS:ProtInc. DR GO; GO:0005886; C:plasma membrane; TAS:Reactome. DR GO; GO:0043235; C:receptor complex; IBA:GO_Central. DR GO; GO:0016167; F:glial cell-derived neurotrophic factor receptor activity; IBA:GO_Central. DR GO; GO:0007399; P:nervous system development; IBA:GO_Central. DR GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:ProtInc. DR Gene3D; 1.10.220.110; GDNF binding domain; 1. DR InterPro; IPR016017; GDNF/GAS1. DR InterPro; IPR037193; GDNF_alpha. DR InterPro; IPR003438; GDNF_rcpt. DR InterPro; IPR003504; GDNF_rcpt_a2. DR InterPro; IPR017372; Glial_neurotroph_fac_rcpt_a1/2. DR PANTHER; PTHR10269:SF4; GDNF FAMILY RECEPTOR ALPHA-2; 1. DR PANTHER; PTHR10269; GDNF RECEPTOR ALPHA; 1. DR Pfam; PF02351; GDNF; 3. DR PIRSF; PIRSF038071; GDNF_family_receptor_alpha; 1. DR PRINTS; PR01318; GDNFRALPHA2. DR PRINTS; PR01316; GDNFRECEPTOR. DR SMART; SM00907; GDNF; 3. DR SUPFAM; SSF110035; GDNF receptor-like; 1. DR Genevisible; O00451; HS. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Cell membrane; Glycoprotein; KW GPI-anchor; Lipoprotein; Membrane; Receptor; Reference proteome; Signal. FT SIGNAL 1..21 FT /evidence="ECO:0000255" FT CHAIN 22..444 FT /note="GDNF family receptor alpha-2" FT /id="PRO_0000010785" FT PROPEP 445..464 FT /note="Removed in mature form" FT /evidence="ECO:0000255" FT /id="PRO_0000010786" FT REGION 363..392 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 363..378 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT LIPID 444 FT /note="GPI-anchor amidated serine" FT /evidence="ECO:0000255" FT CARBOHYD 52 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 357 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 413 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT VAR_SEQ 14..146 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:9182803, ECO:0000303|Ref.4" FT /id="VSP_001661" FT VAR_SEQ 14..118 FT /note="Missing (in isoform 3)" FT /evidence="ECO:0000303|Ref.4" FT /id="VSP_046112" FT VARIANT 462 FT /note="L -> Q (in dbSNP:rs1128397)" FT /evidence="ECO:0000269|PubMed:9182803, FT ECO:0000269|PubMed:9259272, ECO:0000269|Ref.4" FT /id="VAR_059976" FT CONFLICT 6 FT /note="V -> A (in Ref. 2; AAB61922)" FT /evidence="ECO:0000305" FT HELIX 40..48 FT /evidence="ECO:0007829|PDB:5MR4" FT HELIX 51..64 FT /evidence="ECO:0007829|PDB:5MR4" FT HELIX 76..86 FT /evidence="ECO:0007829|PDB:5MR4" FT TURN 89..92 FT /evidence="ECO:0007829|PDB:5MR4" FT HELIX 102..111 FT /evidence="ECO:0007829|PDB:5MR4" FT HELIX 160..169 FT /evidence="ECO:0007829|PDB:5MR5" FT HELIX 172..186 FT /evidence="ECO:0007829|PDB:5MR5" FT STRAND 193..195 FT /evidence="ECO:0007829|PDB:5MR4" FT HELIX 197..210 FT /evidence="ECO:0007829|PDB:5MR5" FT HELIX 213..220 FT /evidence="ECO:0007829|PDB:5MR5" FT HELIX 227..235 FT /evidence="ECO:0007829|PDB:5MR5" FT HELIX 239..242 FT /evidence="ECO:0007829|PDB:5MR5" FT HELIX 251..260 FT /evidence="ECO:0007829|PDB:5MR5" FT HELIX 262..275 FT /evidence="ECO:0007829|PDB:5MR5" FT STRAND 279..281 FT /evidence="ECO:0007829|PDB:5MR5" FT HELIX 286..288 FT /evidence="ECO:0007829|PDB:5MR5" FT HELIX 290..298 FT /evidence="ECO:0007829|PDB:5MR5" FT TURN 299..302 FT /evidence="ECO:0007829|PDB:5MR5" FT STRAND 307..309 FT /evidence="ECO:0007829|PDB:5MR5" FT STRAND 314..316 FT /evidence="ECO:0007829|PDB:5MR5" FT STRAND 319..322 FT /evidence="ECO:0007829|PDB:5MR5" FT HELIX 329..331 FT /evidence="ECO:0007829|PDB:5MR5" FT HELIX 332..343 FT /evidence="ECO:0007829|PDB:5MR5" FT HELIX 346..355 FT /evidence="ECO:0007829|PDB:5MR5" SQ SEQUENCE 464 AA; 51544 MW; 8BC61529530FF21F CRC64; MILANVFCLF FFLDETLRSL ASPSSLQGPE LHGWRPPVDC VRANELCAAE SNCSSRYRTL RQCLAGRDRN TMLANKECQA ALEVLQESPL YDCRCKRGMK KELQCLQIYW SIHLGLTEGE EFYEASPYEP VTSRLSDIFR LASIFSGTGA DPVVSAKSNH CLDAAKACNL NDNCKKLRSS YISICNREIS PTERCNRRKC HKALRQFFDR VPSEYTYRML FCSCQDQACA ERRRQTILPS CSYEDKEKPN CLDLRGVCRT DHLCRSRLAD FHANCRASYQ TVTSCPADNY QACLGSYAGM IGFDMTPNYV DSSPTGIVVS PWCSCRGSGN MEEECEKFLR DFTENPCLRN AIQAFGNGTD VNVSPKGPSF QATQAPRVEK TPSLPDDLSD STSLGTSVIT TCTSVQEQGL KANNSKELSM CFTELTTNII PGSNKVIKPN SGPSRARPSA ALTVLSVLML KLAL //